Mathematical modeling of tumor growth and treatment: triple negative breast cancer
From MaRDI portal
Publication:2095683
DOI10.1016/j.matcom.2022.09.005OpenAlexW4296177499MaRDI QIDQ2095683
Publication date: 17 November 2022
Published in: Mathematics and Computers in Simulation (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.matcom.2022.09.005
Cites Work
- Mathematical modeling of regulatory T cell effects on renal cell carcinoma treatment
- A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy
- Modeling immunotherapy of the tumor -- immune interaction
- A methodology for performing global uncertainty and sensitivity analysis in systems biology
- Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line
- A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept
- Mathematical modeling of ER-positive breast cancer treatment with AZD9496 and palbociclib
- Bistability in a model of tumor-immune system interactions with an oncolytic viral therapy
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
- The role of CD200-CD200R in tumor immune evasion
- Qualitative behavior of systems of tumor-CD4+-cytokine interactions with treatments
- Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+ breast cancer
This page was built for publication: Mathematical modeling of tumor growth and treatment: triple negative breast cancer